MedPath

Lactobacillus

Generic Name
Lactobacillus
Indication

主要用于消化不良以及场内异常发酵,小儿饮食不当引起的腹泻及营养不良等;也用于使用抗生素及放、化疗后引起的菌群失调性腹泻及急性肠胃炎、腹泻、痢疾等。

Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB

Phase 2
Completed
Conditions
Lower Urinary Tract Symptoms
Interventions
First Posted Date
2016-04-22
Last Posted Date
2020-04-24
Lead Sponsor
Medstar Health Research Institute
Target Recruit Count
7
Registration Number
NCT02748356
Locations
🇺🇸

Children's National Medical Center, Washington, District of Columbia, United States

🇺🇸

MedStar National Rehabilitation Hospital, Washington, District of Columbia, United States

The Probiotic Study: Using Bacteria to Calm Your Mind

Phase 2
Completed
Conditions
Anxiety
Abdominal Pain
Interventions
First Posted Date
2016-03-17
Last Posted Date
2019-01-03
Lead Sponsor
Nancy Zucker
Target Recruit Count
9
Registration Number
NCT02711800
Locations
🇺🇸

Duke Center for Developmental Epedimiology, Durham, North Carolina, United States

Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment

First Posted Date
2015-06-11
Last Posted Date
2018-09-07
Lead Sponsor
Medical University of Bialystok
Target Recruit Count
60
Registration Number
NCT02469545
Locations
🇵🇱

Department of Psychiatry, Medical University of Bialystok, Bialystok, Poland

Effect of Probiotics on Chronic Periodontitis in Smoker and Non- Smokers

Phase 3
Completed
Conditions
Chronic Periodontitis
Interventions
First Posted Date
2014-12-31
Last Posted Date
2017-01-10
Lead Sponsor
Next Gen Pharma India Pvt. Ltd.
Target Recruit Count
60
Registration Number
NCT02329353
Locations
🇮🇳

Krishnadevaraya College of Dental Sciences and Hospital, Bangalore, Karnataka, India

Pilot Study of the Effectiveness of Probiotics and Lactitol for the Decolonization of OXA-48 (Carbapenemase) Producing Klebsiella Pneumoniae Among Rectal Carriers

Phase 2
Conditions
Bacterial Colonization
Interventions
First Posted Date
2014-12-04
Last Posted Date
2014-12-05
Lead Sponsor
Instituto de Investigación Hospital Universitario La Paz
Target Recruit Count
20
Registration Number
NCT02307383
Locations
🇪🇸

Hospital Universitario La Paz, Madrid, Spain

Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome

Phase 4
Completed
Conditions
Irritable Bowel Syndrome
Interventions
Drug: Placebo comparator
Other: Run in period
Other: Wash - out period
First Posted Date
2013-06-26
Last Posted Date
2014-09-29
Lead Sponsor
University of Stellenbosch
Target Recruit Count
81
Registration Number
NCT01886781
Locations
🇿🇦

Netcare Greenacres Hospital, Port Elizabeth, Eastern Cape, South Africa

A Phase III Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation

Phase 3
Withdrawn
Conditions
Oral Mucositis in Patients Undergoing HSCT
Interventions
First Posted Date
2013-02-25
Last Posted Date
2016-11-09
Lead Sponsor
All India Institute of Medical Sciences, New Delhi
Registration Number
NCT01797952
Locations
🇮🇳

Institute Rotary Cancer Hospital,All India Institute of Medical Sciences, New delhi, Delhi, India

Lactobacillus Preparation on the Incidence of Diarrhea

Phase 4
Conditions
Diarrhea
Death
Pneumonia
Interventions
First Posted Date
2013-02-15
Last Posted Date
2013-02-15
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
124
Registration Number
NCT01792739
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam, Bundang-Gu, Korea, Republic of

🇰🇷

Myongji Hospital, Goyang, Deokyang-gu, Korea, Republic of

🇰🇷

SMG-SNU Boramae Medical Center, Seoul, Dongjak-gu, Korea, Republic of

Probiotics in Patients With Moderate-to-severe Distention/ Bloating From Systemic Sclerosis

Phase 4
Withdrawn
Conditions
Scleroderma
Interventions
First Posted Date
2011-12-22
Last Posted Date
2016-12-22
Lead Sponsor
University of Michigan
Registration Number
NCT01497743

A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation

Phase 2
Completed
Conditions
Oral Mucositis
Interventions
First Posted Date
2011-11-28
Last Posted Date
2013-02-20
Lead Sponsor
All India Institute of Medical Sciences, New Delhi
Target Recruit Count
31
Registration Number
NCT01480011
Locations
🇮🇳

All India institute of Medical sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath